AMPLIDYNE INC
S-8, 1999-12-16
ELECTRONIC COMPONENTS, NEC
Previous: MEDICONSULT COM INC, S-8, 1999-12-16
Next: AMPLIDYNE INC, S-3, 1999-12-16




AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 16, 1999,
                                                  REGISTRATION NO. 333-_________

                              -------------------

                       SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C.

                              -------------------

                                    FORM S-8

                             REGISTRATION STATEMENT

                                      UNDER

                           THE SECURITIES ACT OF 1933

                              -------------------

                                 AMPLIDYNE, INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                 DELAWARE                                22-3440510
          ------------------------                   -------------------
          (STATE OR OTHER JURIS-                      (I.R.S. EMPLOYER
          DICTION OF ORGANIZATION)                   IDENTIFICATION NO.)

                      59 LAGRANGE STREET, RARITAN, NJ 08869
               ---------------------------------------------------
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

                            1996 INCENTIVE STOCK PLAN

                            (FULL TITLE OF THE PLAN)

                                DEVENDAR S. BAINS
                                    PRESIDENT
                                 AMPLIDYNE, INC.
                               59 LAGRANGE STREET
                                RARITAN, NJ 08869

                     ---------------------------------------
                     (NAME AND ADDRESS OF AGENT FOR SERVICE)

                                 (908) 253-6870
                     ---------------------------------------
                     (TELEPHONE NUMBER, INCLUDING AREA CODE,
                              OF AGENT FOR SERVICE)

                                                              CONTINUED OVERLEAF
<PAGE>


                         CALCULATION OF REGISTRATION FEE
================================================================================
                                                     PROPOSED
                                    PROPOSED         MAXIMUM
TITLE OF           AMOUNT           MAXIMUM          AGGREGATE      AMOUNT OF
SECURITIES         TO BE            OFFERING PRICE   OFFERING       REGISTRATION
TO BE REGISTERED   REGISTERED(1)    PER SHARE        PRICE          FEE
- ----------------   -------------    --------------   -----------    ------------

Common Stock       1,500,000(2)     $8.3125(3)       $12,468,750    $3,466.31

Total                                                               $3,466.31


(1) In  addition,  pursuant  to Rule 416 under the  Securities  Act of 1933,  as
amended   ("Securities  Act"),  this  registration   statement  also  covers  an
indeterminate  number  of  shares  as may be  required  by  reason  of any stock
dividend, recapitalization,  stock split, reorganization, merger, consolidation,
combination or exchange of shares or other similar change affecting the stock.

(2) Includes  1,500,000 shares of Common Stock reserved under the 1996 Incentive
Stock Plan.

(3) Estimated  solely for the purpose of calculating the  registration fee based
upon the  closing  price of the shares of Common  Stock on  December  9, 1999 of
$8-5/16 reported on The Nasdaq SmallCap Market.

<PAGE>


                                     PART I

              INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS


ITEM 1.  Plan Information

ITEM 2.  Registrant Information and Employee Plan Annual Information

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  Incorporation of Documents By Reference

         The  following  documents,  as filed with the  Securities  and Exchange
Commission by Amplidyne,  Inc., a Delaware corporation (the "Corporation"),  are
incorporated herein by reference:

(1)      Annual Report on Form 10-KSB for the period ended December 31, 1998.

(2)      Quarterly Report on Form 10-QSB for the quarter ended March 31, 1999.

(3)      Quarterly Report on Form 10-QSB/A for the quarter ended June 30, 1999.

(4)      Current Report on Form 8-K filed August 3, 1999.

(5)      Quarterly  Report on Form 10-QSB for the quarter  ended  September  30,
1999.

(6)      Proxy Statement on Schedule 14A dated November 26, 1999.

(7)      The  description  of the  Common  Stock,  par  value  $.0001  per share
("Common Stock"), of the Corporation contained in the Corporation's registration
statement filed under Section 12 of the Exchange Act, including any amendment or
report filed for the purpose of updating such description.

All documents filed by the Corporation  pursuant to Section 13(a),  13(c), 14 or
15(d) of the  Securities  Exchange  Act of 1934,  as amended  ("Exchange  Act"),
subsequent to the effective date of this Registration Statement and prior to the
filing of a post-effective  amendment which indicate that all securities offered
have been sold or which registers all securities then remaining unsold, shall be
deemed to be incorporated by reference in the  Registration  Statement and to be
part thereof from the date of filing such documents.  Any statement contained in
a document  incorporated or deemed to be incorporated by reference  herein shall
be deemed  to be  modified  or  superseded  for  purposes  of this  registration
statement  to the  extent  that a  statement  contained  herein  or in any other
subsequently  filed  document which also is or is deemed to be  incorporated  by
reference  herein modifies or supersedes  such statement.  Any such statement so
modified or superseded shall not be deemed, except as so modified or superseded,
to constitute a part of this registration statement.

                                       2
<PAGE>


ITEM 4.  Description of Securities.

Not Applicable.

ITEM 5.  Interests of Named Experts and Counsel

Not Applicable.

ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS

         The Company's  Certificate of  Incorporation  provides that the Company
shall  indemnify its officers and directors to the fullest  extent  permitted by
Section 145 of the Delaware General Corporation Law ("DGCL").

         Section  145  of  the  DGCL  permits  a  corporation,  under  specified
circumstances, to indemnify its directors, officers, employees or agents against
expenses  (including  attorney's  fees),  judgments,  fines and amounts  paid in
settlements  actually and  reasonably  incurred by them in  connection  with any
action,  suit or proceeding  brought by third parties by reason of the fact that
they were or are directors, officers, employees or agents of the corporation, if
such  directors,  officers,  employees  or agents  acted in good  faith and in a
manner they reasonably believed to be in or not opposed to the best interests of
the corporation and, with respect to any criminal action or proceedings,  had no
reason to believe their conduct was unlawful.  In a derivative action, i.e., one
by or in the  right of the  corporation,  indemnification  may be made  only for
expenses actually and reasonably incurred by directors,  officers,  employees or
agent in connection  with the defense or  settlement  of an action or suit,  and
only with  respect  to a matter as to which  they shall have acted in good faith
and in a manner  they  reasonably  believed  to be in or not opposed to the best
interests of the corporation,  except that no  indemnification  shall be made if
such person shall have been adjudged liable to the corporation,  unless and only
to the  extent  that the court in which the  action  or suit was  brought  shall
determine upon application that the defendant directors,  officers, employees or
agents are fairly and reasonably entitled to indemnify for such expenses despite
such adjudication of liability.

         In addition, the Company's Certificate of Incorporation  eliminates the
personal  liability of directors to the fullest extent  permitted by Section 102
of the DGCL.

ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED

Not Applicable.

                                        3
<PAGE>


ITEM 8.  EXHIBITS

The  following  is a  complete  list  of  exhibits  filed  as  a  part  of  this
registration statement:

Exhibit No.       Document
- -----------       --------

5.1               Opinion of Berlack, Israels & Liberman LLP.

10.1              1996 Incentive Stock Plan

23.1              Consent  of  Berlack,  Israels &  Liberman  LLP  (included  in
                  Exhibit 5.1).

23.2              Consent of Grant Thornton LLP.


ITEM 9.  UNDERTAKINGS

A.       The undersigned registrant hereby undertakes:

(1)      To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement;

(i)      To  include  any  prospectus   required  by  section  10(a)(3)  of  the
Securities Act of 1933;

(ii)     To  reflect in the  prospectus  any facts or events  arising  after the
effective date of the registration  statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental change in the information set forth in the registration statement;

(iii)    To  include  any  material  information  with  respect  to the  plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such  information in the  registration  statement;  PROVIDED,
HOWEVER,  that paragraphs  (1)(i) and (1)(ii) do not apply if the information is
required to be included in a  post-effective  amendment by those  paragraphs  is
contained in periodic reports filed by the registrant  pursuant to Section 13 or
15(d) of the Exchange Act that are incorporated by reference in the registration
statement;

(2)      That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities  at that time be deemed to be the initial BONA FIDE
offering thereof; and;

(3)      To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

                                       4
<PAGE>


B.       The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable,  each filing of an employee benefit
plan's  annual  report  pursuant to Section  15(d) of the Exchange  Act) that is
incorporated by reference in the registration  statement shall be deemed to be a
new registration  statement  relating to the securities  offered herein, and the
offering of such  securities at that time shall be deemed to be the initial BONA
FIDE offering thereof.

C.       Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the registrant pursuant to the provisions described in item 6, or otherwise, the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
registrant of expenses  incurred or paid by a director,  officer or  controlling
person of the  registrant  in the  successful  defense  of any  action,  suit or
proceeding,  is  asserted by such  director,  officer or  controlling  person in
connection with the securities being registered,  the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit  to a  court  of  appropriate  jurisdiction  the  question  whether  such
indemnification  by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.

                                       5
<PAGE>


                                   SIGNATURES

         Pursuant to the  requirement of the Securities Act of 1933, as amended,
the  Registrant,  certifies  that it has  reasonable  grounds to believe that it
meets  all the  requirements  for  filing on Form S-8 and has duly  caused  this
Registration Statement to be signed on its behalf by the undersigned,  thereunto
duly authorized, in Raritan, New Jersey, on the 13th day of December, 1999.

                                 AMPLIDYNE, INC.


                                 By:  /s/ DEVENDAR S. BAINS
                                      ------------------------------------------
                                          Devendar S. Bains
                                          Chairman of the Board, President,
                                          Chief Executive Officer, Treasurer and
                                          Principal Accounting Officer

         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Registration  Statement  or  Amendments  thereto  has been  signed  below by the
following persons in the capacities and on the dates indicated.

Signature                Title                                 Date
- ---------                -----                                 ----

/s/ DEVENDAR S. BAINS    Chairman of the Board,                December 13, 1999
- ----------------------   President, Chief Executive Officer,
Devendar S. Bains        Treasurer and Principal
                         Accounting Officer


/s/ TARLOCHAN BAINS      Vice President                        December 13, 1999
- ----------------------
Tarlochan Bains


/s/ NIRMAL BAINS         Secretary                             December 13, 1999
- ----------------------
Nirmal Bains


/s/ CHARLES J. RITCHIE   Director                              December 13, 1999
- ----------------------
Charles J. Ritchie


/s/ MANISH V. DETROJA    Director                              December 13, 1999
- ----------------------
Manish V. Detroja

                                       6
<PAGE>


                                 AMPLIDYNE, INC.

                                    EXHIBITS

                                       TO

                       REGISTRATION STATEMENT ON FORM S-8

<PAGE>


                                INDEX TO EXHIBITS




Exhibit No.       Document
- -----------       --------


5.1               Opinion of Berlack, Israels & Liberman LLP.

10.1              1996 Incentive Stock Plan

23.1              Consent  of  Berlack,  Israels &  Liberman  LLP  (included  in
                  Exhibit 5.1).

23.2              Consent of Grant Thornton LLP.




                                   EXHIBIT 5.1


                   OPINION OF BERLACK, ISRAELS & LIBERMAN LLP

<PAGE>


                 [LETTERHEAD OF BERLACK, ISRAELS & LIBERMAN LLP]


                                                               December 13, 1999


Amplidyne, Inc.
59 LaGrange Street
Raritan, NJ  08869

Ladies and Gentlemen:

         We have acted as counsel for  Amplidyne,  Inc., a Delaware  corporation
(the  "Company"),  in  connection  with a  Registration  Statement  on Form  S-8
("Registration Statement") being filed contemporaneously herewith by the Company
with the Securities and Exchange Commission under the Securities Act of 1933, as
amended (the "Securities  Act"),  covering an aggregate of 1,500,000 shares (the
"Shares") of the Company's Common Stock, $.0001 par value ("Common Stock"),  all
of which are issuable under the Company's 1996 Incentive  Stock Plan (the "Stock
Plan").

         In that  connection,  we have examined the Certificate of Incorporation
and the By-Laws of the Company, the Registration Statement,  the Stock Plan, and
such other  instruments  and  documents  as we have  deemed  relevant  under the
circumstances.

         In making the aforesaid  examinations,  we have assumed the genuineness
of all  signatures  and the  conformity  to  original  documents  of all  copies
furnished to us as original or photostatic copies. We have also assumed that the
corporate records of the Company include all corporate  proceedings taken by the
Company to date.

         Based upon and subject to the foregoing, we are of the opinion that the
Shares have been duly and validly  authorized  and,  when issued and paid for as
described in the Stock Plan or stock option  agreements  issued  pursuant to the
Stock Plan, as the case may be, will be duly and validly issued,  fully paid and
nonassessable.

         We hereby  consent to the use of this opinion as herein set forth as an
exhibit to the Registration Statement.


                                             Very truly yours,


                                             /s/ Berlack, Israels & Liberman LLP
                                             -----------------------------------
                                                 BERLACK, ISRAELS & LIBERMAN LLP



                                  EXHIBIT 10.1

                            1996 INCENTIVE STOCK PLAN

<PAGE>


                                 AMPLIDYNE, INC.
                        1996 INCENTIVE STOCK OPTION PLAN
                    (Adopted by the Board of Directors as of
                       May 1, 1996 and by the Stockholders
                        of the Company as of May 1, 1996)



         1.   PURPOSE.  The purpose of the 1996 Incentive Stock Option Plan (the
"Plan") is to enable Amplidyne,  Inc. (the "Company") to encourage key employees
and  Directors  to  contribute  to the success of the  Company by granting  such
individuals   qualified  options.  In  addition,   non-employee   directors  may
participate in the Plan as provided herein. Options granted pursuant to the Plan
shall consist of qualified stock options.

         2.   ADMINISTRATION.  The Plan  shall be  administered  by the Board of
Directors of the Company or by a Stock Option and  Compensation  Committee  (the
"Committee") appointed by the Board of Directors and consisting of not less than
three  (3)  members  of  the  Board  of  Directors,  each  of  whom  shall  be a
"disinterested  person"  within the meaning of Rule 16b-3 (or any successor rule
or  regulation)  promulgated  under  the  Securities  Exchange  Act of 1934 (the
"Exchange Act"). The Board of Directors may from time to time appoint members of
the Committee in substitution for or in addition to members previously appointed
and may fill vacancies, however caused, on the Committee. No member of the Board
of Directors who is at the time, or within the preceding  year was,  eligible to
participate  in the Plan or in any similar  plan of the  Committee or any of its
affiliates shall be a member of the Committee.

         The Board of Directors  shall determine the purchase price of the stock
covered by each options,  employees and directors to whom, and the time or times
at which,  options shall be granted,  the number of shares to be covered by each
option,  and the term of each option. In addition,  the Board of Directors shall

                                       1
<PAGE>


have the power and  authority to interpret  the Plan,  to  prescribe,  amend and
rescind rules and  regulations  relating to the Plan, to determine the terms and
provisions of the respective  option  agreements  (which need not be identical),
and to make all other  determinations  deemed  necessary  or  advisable  for the
administration  of the Plan. If the Committee is  appointed,  it shall  exercise
such powers and duties, subject to the consent of the Board of Directors and the
provisions of the Plan.

         If the Committee is appointed,  the Board of Directors  shall designate
one of the members of the  Committee  as chairman and the  Committee  shall hold
meetings at such times and places as it shall deem advisable.  A majority of the
Committee members shall constitute a quorum. All determinations of the Committee
shall be made by a  majority  of its  members.  Any  decision  or  determination
reduced to writing  and signed by all the  Committee  members  shall be fully as
effective  as if it had been made by a vote at a meeting  duly  called and held.
The  committee  shall keep minutes of its meetings and shall make such rules and
regulations for the conduct of its business as it shall deem advisable.

         3.   GRANTEES.  Subject to Section 2 hereof,  options may be granted to
such key  employees  and  directors  (including  non-employee  directors) of the
Company and its  subsidiaries  as  determined  by the Board of  Directors or the
Committee (each such employee a "Grantee").

                                       2
<PAGE>


         4.   EFFECTIVENESS AND TERMINATION OF PLAN. The Plan shall terminate on
the earliest of:

              (a)   The tenth  anniversary  of the effective  date as determined
under this Section 4;

              (b)   The date when all shares of the Company's  Common Stock, par
value $.0001 per share (the  "Shares"),  reserved  for  issuance  under the Plan
shall have been acquired through exercise of options granted under the Plan; or

              (c)   Such earlier date as the Board of Directors may determine.

         The Plan shall become  effective as of the date of adoption  thereof by
the Board of Directors  of the Company,  or the date the Plan is approved by the
stockholders, whichever is earlier. Any option outstanding under the Plan at the
time of the Plan's  termination  shall remain in effect in  accordance  with its
terms and conditions and those of the Plan.

         5.   THE SHARES.  Subject to the provisions of Section 7, the aggregate
number of Shares  which may be issued  under the Plan shall be  1,500,000.  Such
number of Shares may be set aside out of the authorized but unissued  Shares not
reserved  for any other  purpose or out of Shares  held in or  acquired  for the
treasury of the Company. If all or part of an option is unexercised,  the Shares
which were not exercised may again be available for grant under the Plan.

         6.   GRANT,  TERMS AND CONDITIONS OF OPTION.  Options may be granted by
the Board of Directors or the  Committee at any time and from time to time prior
to the termination of the Plan. Except as hereinafter provided,  options granted
pursuant to the Plan shall be subject to the following terms and conditions.

              (a)   The purchase  price of the Shares subject to an option shall
be  determined by the Board of Directors or the  Committee  whose  determination
shall be final; it being  understood and agreed that the purchase price need not
be, nor may it be less than,  the fair market  value of the Common  Stock on the
date that the option is granted.

                                       3
<PAGE>


         The exercise  price shall be paid in full in United  States  dollars in
cash or by check at the time of  exercise.  At the  discretion  of the  Board of
Directors  or the  Committee,  the  exercise  price may be paid with (i)  Shares
already owned by, and in the possession of, the Grantee or (ii) any  combination
of United States dollars or Shares.  Anything  contained  herein to the contrary
notwithstanding,  any required  withholding  tax shall be paid by the Grantee in
full in United States  dollars in cash or by check at the time of exercise of an
option.  Shares used to satisfy the exercise  price of an option shall be valued
at their fair market  value as of the close of  business on the day  immediately
preceding  the  date of  exercise.  The  exercise  price  shall  be  subject  to
adjustment,  but only as provided in Section 7 hereof.  The Company may lend the
Grantee funds sufficient to pay the exercise price,  subject to limitations that
may be established by the Board of Directors or the Committee.

              (b)   DURATION AND  EXERCISE OF OPTIONS.  An option may be granted
for a term not  exceeding  ten (10)  years  from  the date of  grant;  provided,
however,  that no grant  for more than five (5) years can be made to a holder of
ten percent (10%) or more of the Company's  outstanding  Common Stock.  Further,
options may not be granted to an  individual  to the extent that in the calendar
year in which such options first becomes  exercisable,  the Common Stock subject
to such  options  has a fair  market  value on the date of  grant in  excess  of
$100,000.  Options shall be  exercisable at such time and in such amounts (up to
the full amount  thereof) as may be  determined by the Board of Directors or the
Committee at the time of grant. If an option is exercisable in installments, the
Board of Directors or the Committee  shall  determine what events,  if any, will
accelerate the exercise of the option.

                                       4
<PAGE>


         The Plan shall be subject to  approval  by the  Company's  stockholders
within  one (1)  year  from the  date on  which  it was  adopted.  Prior to such
stockholder approval, options may be granted under the Plan, but any such option
shall not be exercisable prior to such stockholder  approval. If the Plan is not
approved by the Company's stockholders, the Plan shall terminate and all options
theretofore granted under the Plan shall terminate and become null and void.

              (c)   TERMINATION  OF  EMPLOYMENT  OR   DIRECTORSHIP.   Except  as
otherwise provided by the Board of Directors or the Committee,  upon termination
of the Grantee's  employment or  resignation  or  termination  from the Board of
Directors, the Grantee's rights to exercise an option shall be as follows:

                    (i)    If  the  Grantee's   employment  or  directorship  is
terminated  on  account  of total and  permanent  disability,  any option may be
exercised, to the extent exercisable on the date of the Grantee's termination of
employment or  directorship,  by the Grantee (or by the Grantee's  estate if the
Grantee dies after termination of employment or directorship) at any time within
one (1) year after  termination  of employment or  directorship  but in no event
after the expiration of the term of the option or stock appreciation  right. For
purposes of the Plan, total and permanent  disability means a mental or physical
condition that prevents a Grantee from  performing his customary  duties for the
Company  for nine  consecutive  months  or an  aggregate  of nine  months in any
12-month period.

                    (ii)   In  the  case  of  a  Grantee  whose   employment  or
directorship is terminated by death,  the Grantee's  estate shall have the right
for a period of one (1) year  following  the date of such death to exercise  the
option to the extent the right to exercise had accrued  prior to the date of the
Grantee's death but in no event after the expiration of the term of the option.

                                       5
<PAGE>


                    (iii)  In  the  case  of  a  Grantee  whose   employment  or
directorship  is terminated for any reason other than death or  disability,  the
Grantee (or the Grantee's  estate in the event of the Grantee's death after such
termination)  may, within the  three-month  period  following such  termination,
exercise an option to the extent the right to exercise had accrued prior to such
termination  but in no event  after the  expiration  of the term of the  option.
Notwithstanding  the  foregoing,  except as  otherwise  provided by the Board of
Directors or the  Committee,  if the  Grantee's  termination  of  employment  or
directorship is on account of material  misconduct or any act that is materially
adverse to the  Company,  the  Grantee's  option  shall expire as of the date of
termination of employment.

                    (iv)   A Grantee's  "estate" shall mean the Grantee's  legal
representative  of any person who  acquires  the right to  exercise an option by
reason of the  Grantee's  death.  The Board of Directors or the Committee may in
its  discretion  require the  transferee  of a Grantee to supply it with written
notice of the Grantee's  death or disability and to supply it with a copy of the
will (in the case of the Grantee's death) or such other evidence as the Board of
Directors or the  Committee  deems  necessary  to establish  the validity of the
transfer of an option.  The Board of Directors or the Committee may also require
the agreement of the  transferee to be bound by all of the terms and  conditions
of the Plan.

              (d)   TRANSFERABILITY  OF OPTIONS.  Options shall be  transferable
only by will or the laws of descent and  distribution  and shall be  exercisable
during the Grantee's lifetime only by the Grantee.

                                       6
<PAGE>


              (e)   MODIFICATION,  EXTENSION AND RENEWAL OF OPTIONS.  Subject to
the terms and  conditions  and within the  limitations of the Plan, the Board of
Directors  or the  Committee  may modify,  extend or renew  outstanding  options
granted under the Plan, or accept the  surrender of  outstanding  options (up to
the extent not theretofore  exercised) and authorize the granting of new options
in   substitution   therefor   (to  the   extent  no   theretofore   exercised).
Notwithstanding  the foregoing,  however,  no  modification  of an option shall,
without the consent of the  Grantee,  alter or impair any rights or  obligations
under any option theretofore granted under the Plan.

              (f)   OTHER TERMS AND  CONDITIONS.  Options may contain such other
provisions,  which shall not be inconsistent  with any of the foregoing terms of
the Plan, as the Board of Directors or the Committee shall deem appropriate.

         7.   ADJUSTMENTS IN THE SHARES.

              (a)   In the event the Shares, as presently constituted,  shall be
changed  into or  exchanged  for a  different  number  or kind of stock or other
securities  of the  Company  or of  another  corporation  (whether  by reason of
merger, consolidation, recapitalization, reclassification, split, reverse split,
combination  of shares,  or  otherwise) or if the number of such Shares shall be
increased  through the payment of a stock  dividend,  there shall be substituted
for or added to each Share  theretofore  appropriated  or thereafter  subject or
which may  become  subject  to an option  under the Plan,  the number of kind of
shares of stock or other securities into which each  outstanding  Share shall be
so changed,  or for which each such Share shall be  exchanged,  or to which each
such Share shall be entitled, as the case may be. Outstanding options shall also
be  appropriately  amended as to price and other  terms as may be  necessary  to
reflect the  foregoing  events.  In the event there shall be any other change in

                                       7
<PAGE>


the  number  or  kind  of the  outstanding  Shares,  or of any  stock  or  other
securities  into which such Shares  shall have been  changed,  or for which such
Shares shall have been exchanged,  then, if the Board of Directors shall, in its
sole discretion,  determine that such change equitably requires an adjustment in
any option  theretofore  granted or which may be  granted  under the Plan,  such
adjustments shall be made in accordance with such determination.

              (b)   Fractional  Shares  resulting from any adjustment in options
pursuant to this  Section 7 may be settled in cash or  otherwise as the Board of
Directors or the  Committee may  determine.  Notice of any  adjustment  shall be
given by the Board of  Directors or the  Committee to each Grantee  whose option
has been  adjusted  and such  adjustment  (whether  or not such notice is given)
shall be effective and binding for all purposes of the Plan.

              (c)   The  Committee  or the  Board of  Directors  shall  have the
power, in the event of the disposition of all or substantially all of the assets
of  the  Company,   or  the  dissolution  of  the  Company,  or  the  merger  or
consolidation of the Company with or into any other  corporation,  or the merger
or consolidation of any other  corporation into the Company,  or the making of a
tender  offer to  purchase  all or a  substantial  portion  of the Shares of the
Company, to amend all outstanding options (upon such conditions as it shall deem
fit) in order to permit the exercise of all such options  prior to the effective
date of any such  transaction and to terminate such options as of such effective
date. If the Board of Directors or the Committee shall exercise such power,  all
options then outstanding and subject to such requirement shall be deemed to have
been amended to permit the  exercise  thereof in whole or in part by the Grantee
at any time or from time to time as  determined by the Board of Directors or the
Committee prior to the effective date of such transaction and such options shall
be deemed to terminate upon such effective date.

                                       8
<PAGE>


         8.   SECURITIES LAW  REQUIREMENTS.  No option  granted  pursuant to the
Plan  shall be  exercisable  in  whole or in part,  nor  shall  the  Company  be
obligated  to sell any Shares  subject to any such option or stock  appreciation
right, if such exercise, sale or settlement would, in the opinion of counsel for
the  Company,  violate  the  Securities  Act of 1933 (or other  Federal or State
statutes having similar requirements), as it may be in effect at that time. Each
option  shall be subject to the  further  requirement  that,  if at any time the
Board  of  Directors  shall  determine  in  its  discretion  that  the  listing,
registration  or  qualification  of the Shares  subject to such option under any
securities exchange  requirements or under any applicable law, or the consent or
approval of any governmental regulatory body, is necessary as a condition of, or
in  connection  with,  the  granting  of such  option or the  issuance of Shares
thereunder,  such  option may not be  exercised  in whole or in part unless such
listing,  registration,  qualification,  consent  or  approval  shall  have been
effected or  obtained  free of any  conditions  not  acceptable  to the Board of
Directors.

         9.   AMENDMENT OF THE PLAN.

              (a)   Options  shall be  evidenced by such form of agreement as is
approved by the Board of Directors or the Committee.  The Board of Directors may
amend the Plan,  may correct any defect or supply any omission or reconcile  any
inconsistency  in the Plan or in any  option in the  manner and to the extent it
shall deem  desirable;  provided,  however,  except as provided in Section 7 and
this Section 9, unless the stockholders of the Company shall have first approved
thereof:  (i) no option shall be exercisable  more than ten years after the date
it is granted;  (ii) the expiration date of the Plan shall not be extended;  and
(iii) no amendment shall be of any force and effect if such amendment  increases
the number of Shares  available  for the  granting  of options  may be  granted,
materially  increases the benefits accruing the Grantees or materially  modifies

                                       9
<PAGE>


the requirements as to eligibility or participation in the Plan. In addition, no
amendment of the Plan shall, without the consent of a Grantee,  adversely affect
the Grantee's rights under any option.

              (b)   The Board of Directors also shall have the power to amend or
terminate  the  Plan in such  respect  as the  Board  of  Directors  shall  deem
advisable in order to ensure  favorable  Federal  income tax  treatment  for the
Company.

         10.  APPLICATION  OF FUNDS.  The proceeds  received by the Company from
the sale of Shares will be used for general corporate purposes.

         11.  NO OBLIGATION TO EXERCISE OPTION.  The granting of an option shall
impose no  obligation  upon the Grantee (or upon a  transferee  of a Grantee) to
exercise such option.

         12.  PLAN NOT A CONTRACT OF  EMPLOYMENT.  The Plan is not a contract of
employment,  and the terms of employment of any Grantee shall not be affected in
any way by the Plan or  related  instruments  except  as  specifically  provided
therein.  The establishment of the Plan shall not be construed as conferring any
legal rights upon any Grantee for a  continuation  of  employment,  nor shall it
interfere  with the right of the  company or any  subsidiary  to  discharge  any
Grantee and to treat him without regard to the effect which such treatment might
have upon him as a Grantee.

         13.  EXPENSES  OF THE PLAN.  All of the  expenses  of the Plan shall be
paid by the Company.

         14.  COMPLIANCE WITH APPLICABLE LAW. Notwithstanding anything herein to
the  contrary,  the  Company  shall  not be  obligated  to cause to be issued or
delivered  any  certificates  for Shares  pursuant to the exercise of an option,
unless and until the Company is advised by its  counsel  that the  issuance  and

                                       10
<PAGE>


delivery  of such  certificates  is in  compliance  with  all  applicable  laws,
regulations or governmental  authority and the requirements of any exchange upon
which Shares are traded.  The Company shall in no event be obligated to register
any  securities  pursuant to the  Securities Act of 1933 (as now in effect or as
hereafter  amended) or to take any other  action in order to cause the  issuance
and delivery of such  certificates  to comply with any such law,  regulation  or
requirement.  The Board of Directors or Committee may require, as a condition of
the issuance and delivery of such certificates and in order to ensure compliance
with  such  laws,  regulations  and  requirements,  that the  Grantee  make such
covenants,   agreements  and  representations  as  the  Board  of  Directors  or
Committee, in its sole discretion, deems necessary or desirable.

         15.  GOVERNING  LAW.  Except the extent  preempted  by Federal law, the
Plan shall be construed  and enforced in accordance  with,  and governed by, the
laws of the State of Delaware.

                                       11



                                  EXHIBIT 23.2


                          CONSENT OF GRANT THORNTON LLP

<PAGE>


                         CONSENT OF INDEPENDENT AUDITORS




         We have  issued  our  report  dated  March 31,  1999  accompanying  the
financial  statements of Amplidyne,  Inc. appearing in the Annual Report on Form
10-KSB for the year ended December 31, 1998 which is  incorporated  by reference
in this  Registration  Statement on Form S-8. We consent to the incorporation by
reference  in the  Registration  Statement  on  Form  S-8 of the  aforementioned
report.





Grant Thornton LLP
Edison, New Jersey

December 13, 1999



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission